OTC Markets OTCQX - Delayed Quote USD

Microbix Biosystems Inc. (MBXBF)

0.2600
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT
Advanced Chart
Loading Chart for MBXBF
  • Previous Close 0.0000
  • Open 0.2600
  • Bid 0.2550 x --
  • Ask 0.2661 x --
  • Day's Range 0.2600 - 0.2600
  • 52 Week Range 0.2000 - 0.3870
  • Volume 59,000
  • Avg. Volume 34,080
  • Market Cap (intraday) 36.825M
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 26.00
  • EPS (TTM) 0.0100
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

www.microbix.com

--

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Microbix Biosystems Inc.

Recent News: MBXBF

View More
View More

Performance Overview: MBXBF

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MBXBF
10.03%
S&P/TSX Composite index (^GSPTSE)
4.35%

1-Year Return

MBXBF
4.84%
S&P/TSX Composite index (^GSPTSE)
15.51%

3-Year Return

MBXBF
25.71%
S&P/TSX Composite index (^GSPTSE)
27.82%

5-Year Return

MBXBF
20.73%
S&P/TSX Composite index (^GSPTSE)
77.07%

Compare To: MBXBF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MBXBF
Microbix Biosystems Inc.
0.2600
0.00%
Mkt Cap 36.825M
Industry Biotechnology
ABCL
AbCellera Biologics Inc.
2.0500
-2.38%
Mkt Cap 611.894M
Industry Biotechnology

Statistics: MBXBF

View More

Valuation Measures

Annual
As of 5/14/2025

  • Market Cap

    36.48M

  • Enterprise Value

    31.76M

  • Trailing P/E

    25.96

  • Forward P/E

    36.36

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.17

  • Price/Book (mrq)

    1.78

  • Enterprise Value/Revenue

    1.93

  • Enterprise Value/EBITDA

    9.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.35%

  • Return on Assets (ttm)

    3.79%

  • Return on Equity (ttm)

    6.85%

  • Revenue (ttm)

    23.03M

  • Net Income Avi to Common (ttm)

    1.92M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.05M

  • Total Debt/Equity (mrq)

    22.29%

  • Levered Free Cash Flow (ttm)

    566.28k

View More

Research Analysis: MBXBF

View More

Revenue vs. Earnings

Revenue 4.25M
Earnings --

Q4'23

Q1'24

Q2'24

Q4'24

0
2M
4M
6M
 

Analyst Price Targets

 
View More

People Also Watch

SRBCF Sirona Biochem Corp.
0.0043
0.00%
 
AVCNF Avicanna Inc.
0.1690
-3.43%
 
BIOAF Bioasis Technologies Inc.
0.0001
0.00%
 
CVALF Covalon Technologies Ltd.
1.8200
0.00%
 
EMMA Emmaus Life Sciences, Inc.
0.0120
0.00%
 
ATBPF Antibe Therapeutics Inc.
0.2156
-0.19%
 
KNBIF Kane Biotech Inc.
0.0541
+0.37%
 
PRKA Parks! America, Inc.
38.00
0.00%
 
EDTXF Spectral Medical Inc.
0.5990
-0.17%
 
MRZM Marizyme, Inc.
0.0003
0.00%
 
APLIF Appili Therapeutics Inc.
0.0210
0.00%
 
SEOVF Sernova Biotherapeutics Inc
0.1600
+10.34%
 
ASAPF Aurora Spine Corporation
0.2200
0.00%
 
DLTNF Humble Grow Co.
0.0076
-5.63%
 
GRUSF Grown Rogue International Inc.
0.3900
-4.88%
 
RVXCF Resverlogix Corp.
0.0300
0.00%